Arterys Cardio DL vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Arterys Cardio DL
by Arterys (now part of Tempus)
VS
Zio AT ECG Monitoring System
by iRhythm Technologies, Inc.

AI Verdict

Arterys Cardio DL is designed for enhancing the analysis of cardiac MRI images, providing automated segmentations and advanced quantification for structural and functional assessment. In contrast, the Zio AT ECG Monitoring System focuses on long-term, continuous ECG monitoring via a wearable device to detect and report cardiac arrhythmias. While both utilize AI in cardiology, they address different diagnostic needs: one for detailed imaging interpretation and the other for electrical activity surveillance.

Choose Arterys Cardio DL if…

Choose Arterys Cardio DL if your primary need is rapid, accurate, and automated analysis of cardiac MRI studies. This tool is ideal for radiologists and cardiologists seeking to reduce interpretation time for ventricle segmentations, perform advanced 4D Flow post-processing, or conduct quantitative delayed enhancement analysis for comprehensive cardiac assessment.

View Arterys Cardio DL →

Choose Zio AT ECG Monitoring System if…

Choose Zio AT ECG Monitoring System if you require continuous, long-term (up to 14 days) ambulatory ECG monitoring for arrhythmia detection in an outpatient setting. This wearable solution is best suited for identifying symptomatic and asymptomatic cardiac events, providing real-time data transmission, and generating comprehensive reports for patients with suspected or known intermittent arrhythmias.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Arterys Cardio DL Zio AT ECG Monitoring System
Pricing Unknown Contact for pricing
Deployment Cloud-based (SaaS), integrates with existing PACS or EHR, web-based zero-footprint viewer (Mac, PC, tablet, phone). [4, 7, 9, 13, 27] Cloud-based (data analytics and clinician portal)
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Arterys Cardio DL

Arterys Cardio DL significantly enhances clinician workflow by reducing cardiac MRI interpretation time from 30-60 minutes to mere seconds through automated, editable ventricle segmentations. This drastic efficiency improvement for a complex diagnostic task makes it highly usable for specialists.

Clinical Value

Tie

Both tools offer substantial and well-validated clinical value. Arterys Cardio DL enhances diagnostic accuracy for cardiac MRI with precise segmentations and advanced analyses like 4D Flow, validated to be as accurate as manual methods. Zio AT ECG Monitoring System provides continuous, AI-powered arrhythmia detection with proven impact on diagnostic yield, reduced retesting, and improved patient outcomes.

Pricing & Value

Zio AT ECG Monitoring System

While both tools require contacting for pricing, Zio AT ECG Monitoring System has publicly available cost-effectiveness studies demonstrating high value from a health economic perspective. These studies show reduced outpatient appointments, fewer emergency department visits, and a favorable incremental cost-effectiveness ratio, offering a more transparent and quantifiable value proposition.

Enterprise Readiness

Tie

Both tools exhibit strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering Business Associate Agreements (BAAs). Both are cloud-based, and Arterys Cardio DL specifically highlights 'vendor-agnostic compatibility,' while Zio AT's cloud-based analytics and clinician portal also imply robust integration capabilities.

Innovation

Arterys Cardio DL

Arterys Cardio DL stands out by claiming to be the 'world's first internet platform for medical imaging' and the 'first FDA-cleared technology leveraging cloud computing and deep learning in a clinical setting.' Its application of deep learning to complex cardiac MRI tasks like 4D Flow post-processing represents a foundational innovation in the field.

Support & Docs

Zio AT ECG Monitoring System

Zio AT ECG Monitoring System provides a comprehensive suite of support resources, including detailed 'Instructions for Use' and 'Clinical Reference Manuals,' 24/7 customer care, a patient-focused mobile app, and dedicated teams for billing and financial assistance. Arterys Cardio DL lacks explicit mention of such extensive support and documentation in the available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Arterys Cardio DL Zio AT ECG Monitoring System
Product Name Arterys Cardio DL Zio AT ECG Monitoring System
Company ARTERYS iRhythm Technologies, Inc.
Core Function Automated, editable ventricle segmentations for cardiac MRI analysis Continuous, AI-powered ECG monitoring for long-term arrhythmia detection
Primary Application Area Cardiac MRI analysis Long-term arrhythmia detection
Key Technology/Method Deep learning algorithms for image analysis; automated ventricle segmentations Wearable Zio AT patch for continuous ECG recording; deep-learned AI algorithm (ZEUS System)
Output/Deliverable Automated, editable ventricle segmentations; 4D Flow post-processing; Quantitative Delayed Enhancement analysis Comprehensive end-of-wear reports; ZioSuiteu00ae clinician portal; MyZiou00ae patient mobile app

Videos

Demos, reviews, and walkthroughs featuring Arterys Cardio DL and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Arterys Cardio DL is designed for automated, editable ventricle segmentations for cardiac MRI analysis, aiming to reduce interpretation time and enhance diagnostic accuracy. The Zio AT ECG Monitoring System provides continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting.
Arterys Cardio DL analyzes cardiac MRI images to provide automated ventricle segmentations and other quantitative data. The Zio AT ECG Monitoring System continuously records and analyzes ECG data from a wearable patch for up to 14 days.
Arterys Cardio DL utilizes deep learning algorithms for image analysis, specifically for automated ventricle segmentations and other quantitative measurements from cardiac MRI. The Zio AT ECG Monitoring System employs an FDA-cleared deep-learned AI algorithm (ZEUS System) for continuous arrhythmia detection from ECG data.
Arterys Cardio DL is a cloud-based software that processes existing cardiac MRI scans, primarily assisting physicians with interpretation and analysis. The Zio AT system involves a wearable Zio AT patch that patients wear for continuous ECG recording, with data transmitted wirelessly to a clinician portal.
Arterys Cardio DL provides automated, editable ventricle segmentations for cardiac MRI, along with 4D Flow post-processing for blood flow visualization and quantification, and Quantitative Delayed Enhancement analysis. The Zio AT ECG Monitoring System delivers comprehensive end-of-wear reports for clinicians, detailing detected symptomatic and asymptomatic cardiac events.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Arterys Cardio DL or Zio AT ECG Monitoring System

Backers

Who funded each tool's parent company.

Zio AT ECG Monitoring System

AI Tool Finder
AI-powered search. Results may not be comprehensive.